DR. CHARLES MERRITT BEASLEY, M.D.
Psychiatric at Beech Knls, Indianapolis, IN
License number
Indiana 01045668A
Category
Psychiatric
Type
Psychiatry
Address
Address
8161 Beech Knls, Indianapolis, IN 46256
Phone
(317) 578-2714
(317) 578-2801 (Fax)
(317) 578-2801 (Fax)
Personal information
See more information about CHARLES MERRITT BEASLEY at radaris.comName
Address
Phone
4454 Greenmeadow Cir, Indianapolis, IN 46235
5312 N Kenmore Rd, Indianapolis, IN 46226
3255 Nicholas Ave, Indianapolis, IN 46218
3093 S 900 E, Greentown, IN 46936
926 N Hart St, Princeton, IN 47670
Professional information
See more information about CHARLES MERRITT BEASLEY at trustoria.com
Dr At Eli Lilly
Dr At Eli Lilly
Position:
Dr at Eli Lilly
Location:
Indianapolis, Indiana Area
Industry:
Pharmaceuticals
Work:
Eli Lilly
since Jul 1987
-
Dr
Education:
University of Cincinnati College of Medicine 1984 - 1987
Residency in Psychiatry, Psychiatry Yale University School of Medicine 1983 - 1984
Internship, Psychiatry University of Kentucky College of Medicine 1979 - 1983
Doctor of Medicine (M.D.), Medicine Yale University 1968 - 1977
BA, Psychology and Computer Science
Residency in Psychiatry, Psychiatry Yale University School of Medicine 1983 - 1984
Internship, Psychiatry University of Kentucky College of Medicine 1979 - 1983
Doctor of Medicine (M.D.), Medicine Yale University 1968 - 1977
BA, Psychology and Computer Science
Dr At Eli Lilly
Dr At Eli Lilly
Position:
Dr at Eli Lilly
Location:
Indianapolis, Indiana Area
Industry:
Pharmaceuticals
Work:
Eli Lilly
since Jul 1987
-
Dr
Education:
Yale University School of Medicine 1983 - 1984
Internship, Psychiatry Yale University 1968 - 1977
BA, Psychology and Computer Science
Internship, Psychiatry Yale University 1968 - 1977
BA, Psychology and Computer Science
Skills:
Psychopharmacology, Clinical Trial Design, Drug Safety Assessment, Clinical Research
Charles Beasley - Indianapolis, IN
Charles Beasley - Indianapolis, IN
Work:
Carters Painting
Painter Cavalier Resort - Indianapolis, IN
Security Guard Hound Dog Recovery - Indianapolis, IN
Recovery Agent JCR - Indianapolis, IN
Painter Flaherty & Collins Properties - Indianapolis, IN
Groundskeeper/Maintenance Fisherman's Villiage - Indianapolis, IN
Punch Out
Painter Cavalier Resort - Indianapolis, IN
Security Guard Hound Dog Recovery - Indianapolis, IN
Recovery Agent JCR - Indianapolis, IN
Painter Flaherty & Collins Properties - Indianapolis, IN
Groundskeeper/Maintenance Fisherman's Villiage - Indianapolis, IN
Punch Out
Dr. Charles M Beasley, Indianapolis IN - MD (Doctor of Medicine)
Dr. Charles M Beasley, Indianapolis IN - MD (Doctor of Medicine)
Specialties:
Neuropsychiatry (Psychiatry)
Address:
Drop Code SUITE 2434, Indianapolis 46285
BUSHONG DERMATOLOGY CENTER
8161 Beech Knls, Indianapolis 46256
(317) 578-2714 (Phone), (317) 277-5974 (Fax)
BUSHONG DERMATOLOGY CENTER
8161 Beech Knls, Indianapolis 46256
(317) 578-2714 (Phone), (317) 277-5974 (Fax)
Certifications:
Psychiatry, 1988
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Kentucky
Graduated: 1983
Hosp St Raphael
U Cincinnati
Yale University
University of Kentucky
Graduated: 1983
Hosp St Raphael
U Cincinnati
Yale University
Method For Treating Dyskinesias With Olanzapine
Method For Treating Dyskinesias With Olanzapine
US Patent:
5776928, Jul 7, 1998
Filed:
Apr 21, 1995
Appl. No.:
8/422177
Inventors:
Charles M. Beasley - Indianapolis IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 3155
US Classification:
514220
Abstract:
The invention provides a method for treating a dyskinesias comprising administering an effective amount of 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno�2,3-b!�1,5! benzodiazepine.
Method For Treating A Tic Disorder
Method For Treating A Tic Disorder
US Patent:
6274636, Aug 14, 2001
Filed:
Feb 16, 1999
Appl. No.:
9/242418
Inventors:
Charles M. Beasley - Indianapolis IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 3155
US Classification:
518220
Abstract:
The invention provides a method for treating a tic disorder comprising administering an effective amount of 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine.
Method For Treating Substance Abuse
Method For Treating Substance Abuse
US Patent:
6159963, Dec 12, 2000
Filed:
Nov 25, 1997
Appl. No.:
8/952845
Inventors:
Charles M Beasley - Indianapolis IN
Kurt Rasmussen - Fishers IN
Gary D Tollefson - Indianapolis IN
Kurt Rasmussen - Fishers IN
Gary D Tollefson - Indianapolis IN
Assignee:
Eli Lilly and Company - Indianapolis IN
International Classification:
A61K 3155
US Classification:
514220
Abstract:
The invention provides a method for treating substance abuse comprising administering an effective amount of olanzapine or pharmaceutically acceptable salt thereof to a patient in need thereof.
Method For Treating Cognitive Dysfunction
Method For Treating Cognitive Dysfunction
US Patent:
2002017, Nov 28, 2002
Filed:
Nov 25, 1997
Appl. No.:
08/952918
Inventors:
CHARLES M BEASLEY JR - INDIANAPOLIS IN, US
International Classification:
A61K031/55, A01N043/62
US Classification:
514/220000
Abstract:
The invention provides a method for treating a cognitive dysfunction comprising administering an effective amount of 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine.
Dr At Eli Lilly
Dr At Eli Lilly
Position:
Dr at Eli Lilly
Location:
Indianapolis, Indiana Area
Industry:
Pharmaceuticals
Work:
Eli Lilly
-
Dr
Mental Disorders
Mental Disorders
US Patent:
5817656, Oct 6, 1998
Filed:
Nov 13, 1996
Appl. No.:
8/748293
Inventors:
Charles M. Beasley - Indianapolis IN
Jiban Kumar Chakrabarti - Frimley, GB2
Terrence Michael Hotten - Hants, GB2
David Edward Tupper - Reading, GB2
Jiban Kumar Chakrabarti - Frimley, GB2
Terrence Michael Hotten - Hants, GB2
David Edward Tupper - Reading, GB2
Assignee:
Eli Lilly and Company - Indianapolis IN
Eli Lilly and Company Limited - Basingstoke
Eli Lilly and Company Limited - Basingstoke
International Classification:
A01N 4362
US Classification:
514220
Abstract:
2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno-�2,3-b!�1,5!benzodiazepine, or an acid salt thereof, has pharmaceutical properties, and is of particular use in the treatment of mental disorders. The compound has the following structure: ##STR1##.